The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
UDR moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 64%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for UDR crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 40%.
Following a +1.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where UDR advanced for three days, in 139 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 114 of 240 cases where UDR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 47%.
The 10-day RSI Indicator for UDR moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 16 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UDR as a result. In 51 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for UDR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 29 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UDR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
UDR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UDR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: UDR's P/B Ratio (4.059) is slightly higher than the industry average of (2.264). P/E Ratio (23.152) is within average values for comparable stocks, (17.966). Projected Growth (PEG Ratio) (6.340) is also within normal values, averaging (6.621). Dividend Yield (0.016) settles around the average of (0.240) among similar stocks. P/S Ratio (6.570) is also within normal values, averaging (5.580).
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UDR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
UDR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 52 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 95 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| NURE | UDR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 64% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 50% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 54% |
| Advances ODDS (%) | 4 days ago 80% | 4 days ago 49% |
| Declines ODDS (%) | 8 days ago 84% | 8 days ago 59% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 42% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 47% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, UDR has been closely correlated with MAA. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if UDR jumps, then MAA could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HIS | 25.42 | 0.05 | +0.20% |
| Humilis US Focused Opportunities ETF (HIS) | |||
| BAMU | 25.31 | -0.02 | -0.06% |
| Brookstone Ultra-Short Bond ETF (BAMU) | |||
| ITOT | 159.38 | -0.34 | -0.21% |
| iShares Core S&P Total U.S. Stock Market ETF (ITOT) | |||
| PML | 6.58 | -0.02 | -0.30% |
| PIMCO Municipal Income FUND II | |||
| MCH | 22.72 | -0.21 | -0.93% |
| Matthews China Active ETF (MCH) | |||